As of May 30, 2024, 72 million shares of our common stock were available for future awards under our equity plans, including 12 million shares approved for issuance under our employee stock purchase plan (“ESPP”).


Nine months ended	May 30, 2024		June 1, 2023

Restricted stock award shares granted	12		14
Weighted-average grant-date fair value per share	$	69.02	$	54.13

For each six-month ESPP offering period that ended in the second quarter of 2024 and 2023, employees purchased 2 million and 3 million shares, respectively, at a share price of $60.68 and $52.45, respectively.

Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $100 million and $88 million was capitalized and remained in inventory as of May 30, 2024 and August 31, 2023, respectively.


	Quarter ended				Nine months ended
	May 30, 2024		June 1, 2023		May 30, 2024		June 1, 2023

Stock-based compensation expense by caption
Cost of goods sold	$	80	$	61	$	227	$	137
Research and development	77		57		222		169
Selling, general, and administrative	60		34		159		107
Restructure	—		(4)		—		(6)
	$	217	$	148	$	608	$	407

Stock-based compensation expense by type of award
Restricted stock awards	$	201	$	129	$	555	$	354
ESPP	16		19		53		53
	$	217	$	148	$	608	$	407

As of May 30, 2024, $1.51 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the third quarter of 2028, resulting in a weighted-average period of 1.3 years.